Skip to main content

Table 3 Correlations between KMT2A gene rearrangement and immunological markers

From: Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children

Immunological marker

KMT2A rearrangement

KMT2A subgroups

Neg (%)

Pos (%)

P

KMT2A-AFF1+ (%)

Other KMT2A+ (%)

P

CD2

 Neg

83 (93)

32 (100)

0.132

16 (100)

16 (100)

–

 Pos

6 (7)

0 (0)

0 (0)

0 (0)

CD5

 Neg

86 (97)

32 (100)

0.293

16 (100)

16 (100)

–

 Pos

3 (3)

0 (0)

0 (0)

0 (0)

CD7

 Neg

86 (97)

25 (78)

0.001

12 (75)

13 (81)

0.669

 Pos

3 (3)

7 (22)

4 (25)

3 (19)

CD20

 Neg

78 (94)

26 (94)

0.999

13 (100)

13 (87)

0.484

 Pos

5 (6)

2 (6)

0 (0)

2 (13)

CD22

 Neg

16 (28)

12 (75)

0.011

8 (73)

4 (44)

0.362

 Pos

41 (72)

8 (25)

3 (27)

5 (56)

CD56

 Neg

46 (84)

18 (86)

0.999

8 (80)

10 (91)

0.586

 Pos

9 (16)

3 (14)

2 (20)

1 (9)

CD58

 Neg

45 (82)

16 (76)

0.581

8 (80)

8 (73)

0.696

 Pos

10 (18)

5 (24)

2 (20)

3 (27)

CD13

 Neg

65 (73)

31 (97)

0.004

15 (94)

16 (100)

0.999

 Pos

24 (27)

1 (3)

1 (6)

0 (0)

CD33

 Neg

34 (38)

26 (81)

< 0.001

15 (94)

11 (69)

0.172

 Pos

55 (62)

6 (19)

1 (6)

5 (31)

CD15

 Neg

50 (91)

10 (48)

< 0.001

1 (10)

9 (82)

0.002

 Pos

5 (9)

11 (52)

9 (90)

2 (18)

CD66c

 Neg

50 (91)

21 (100)

0.153

10 (100)

11 (100)

–

 Pos

5 (9)

0 (0)

0 (0)

0 (0)

CD34

 Neg

9 (19)

17 (53)

< 0.001

6 (38)

11 (69)

0.077

 Pos

80 (90)

15 (47)

10 (62)

5 (31)

CD133

 Neg

39 (71)

9 (43)

0.023

1 (10)

8 (73)

0.008

 Pos

16 (29)

12 (57)

9 (90)

3 (27)

NG2

 Neg

43 (78)

3 (14)

< 0.001

0 (0)

3 (73)

0.214

 Pos

12 (22)

18 (86)

10 (100)

8 (27)

  1. Italic signifies P < 0.05